Avascular Necrosis Market Size 2020| Future Trends, Growth Analysis, Top Manufacturers and Regional Insights, Forecast To 2024
Avascular
Necrosis Market Insights
Avascular
necrosis (AVN) occurs when bone tissue begins to die due to a lack of
sufficient supply of blood. The condition is often caused by joint or bone
trauma, long-term steroid use or alcohol abuse. Market Research Future has
released a report on the global avascular necrosis market which reveals that
the global market is expected to grow at a CAGR 6.58% during the forecast
period from 2018 to 2024.
The
disease has been observed to commonly affect men between the ages of 30 to 50
years and has been particularly high in occurrence in emerging economies.
Surgery is an inevitable part of avascular necrosis, and medication is required
to treat the condition, thus driving the global Avascular
Necrosis Market Size.
Moreover, this factor is also driving the demand for minimally invasive
treatment options. Notably, avascular necrosis or osteonecrosis is a
challenging condition to diagnose and can often be overlooked until it has
approached a later stage, and no known cure exists. This factor has driven
R&D activities on the part of market players with a focus on drug
discovery.
Medical
implants are restricted by stringent regulations which are aimed at improvement
of quality, this has adversely affected the cost of surgery and restrains the
global avascular necrosis market. Moreover, there is a shortage of skilled
orthopedic surgeons which further challenges the market. However, due to the
high demand for non-surgical treatment, drug development activities are
expected to reveal opportunities in the coming years.
Avascular
Necrosis Market Segmentation
MRFR's
detailed report includes segmentation of the global avascular necrosis market
on the basis of type, site, diagnosis, treatment, end-user, and region. Types
of avascular necrosis recorded in the report include trauma-related avascular
necrosis and non-trauma related avascular necrosis. Between these, non-trauma
related AVN accounts for a larger share of the market due to increasing cases
of alcoholism and illegal steroid use. Avascular necrosis can occur largely in
the hip bone, knee, shoulder, and others. Hip bones have been observed to have
the largest share of the market.
By
diagnosis, the market is divided between imaging and biopsy; the former is a
more preferred form of diagnosis as it is minimally invasive, and is vital is
early diagnoses of the disease. Treatment of avascular necrosis includes
electrical stimulation, medication, gene therapy, and surgery. Surgery accounts
for the leading segment as it is the only method of treatment which provides
long-term relief. However, gene therapy is an up and coming treatment option
which is expected to witness rapid growth. By end-users, the market is
segmented into hospitals & clinics, ambulatory surgical centers, and
diagnostic centers.
Regional
Analysis
The
Americas is the leading regional segment for avascular necrosis primarily due
to the concentration of market players in the region. The affinity toward
adoption of technically advanced medical treatments and practices have
propelled the regional market into a leadership position with the U.S and
Canada being key country-level markets. The Asia Pacific is expected to grow at
the highest CAGR during the forecast period due to the increasing prevalence of
the disease in the emerging economies present in the region. Manufacturing of
medical devices is increasingly shifting to countries such as China and India
due to cheap labor costs and the low investments necessary toward the set-up of
infrastructure.
Key
Players
Market
players that have significantly impacted the global avascular necrosis market
have been recorded in the report and include Integra LifeSciences Corporation,
Bayer AG, Eli Lilly and Company, Bristol-Myers Squibb, Medtronic Plc, Merck
KGaA, Sanofi, Zimmer Biomet Holdings, Pfizer Inc, Boehringer Ingelheim.
Latest
Industry News
Regrow
Biosciences has developed cell therapy for the treatment of orthopedic
conditions including early stage avascular necrosis. Clinical trials are set to
begin in the U.S and Europe soon.
Browse other healthcare-related
reports
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact:
Comments
Post a Comment